BREAKING NEWS

Teva, one of the largest generic opioid manufacturers, reached a tentative $4.25 billion settlement over its role in the ongoing crisis.

Tuesday, July 26, 2022 6:47 PM ET

The deal came after a series of blistering trials and previous settlements in individual cases across the country over the past year. Though much lesser-known, Teva and its affiliates produced far more prescription opioids during the peak years of the crisis than marquee-name opioid manufacturers such as Johnson & Johnson did.

Read the latest